Intrommune Therapeutics Presents Supporting Data
OMIT (Oral Mucosal Immunotherapy) is a new approach to the management of food allergy demonstrating a robust immunologic response in treated subjects...
Source: globenewswire.com
Stuart Loesch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stuart Loesch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stuart Loesch Today - Breaking & Trending Today
Intrommune Therapeutics Completes Last Patient Last Visit
Full safety and efficacy data presentation planned for Q4...
Source: globenewswire.com
Movers & Shakers: Lyell Immunopharma, Radionetics Oncology, AlivaMab Discovery and More
Life sciences companies made adjustments to their leadership teams with multiple appointments for chief commercial officers, chief business officers and more with this week’s Movers & Shakers.
Source: biospace.com
Intrommune Expands and Strengthens Senior Leadership Team
Appointment of Stuart Loesch as President Leverages His Strong Leadership Abilities and Extensive Expertise in Allergy and Pharmaceutical Development ...
Source: globenewswire.com
ALK Acquires OTIPRIO® (ciprofloxacin otic suspension), Broadening Treatment Solutions for Healthcare Providers and Patients
/PRNewswire/ -- ALK (ALKB:DC / OMX:ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of...
Source: prnewswire.com